Context Therapeutics Inc.

For the period ended Dec 31, 2025. Filed Mar 23, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Mar 23, 2026

CNTX$0.20+3.5%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets

	December 31,
	2025	2024
Assets
Current assets:
Cash and cash equivalents	$65,995,228	$94,429,824
Prepaid expenses and other current assets	2,358,474	3,466,160
Total current assets	68,353,702	97,895,984
Operating lease right-of-use asset	110,410	218,816
Property and equipment, net	29,656	11,959
Total assets	$68,493,768	$98,126,759
Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable	$2,532,887	$1,452,188
Accrued expenses and other current liabilities	5,375,090	1,188,929
Operating lease liability - current	112,064	107,316
Total current liabilities	8,020,041	2,748,433
Operating lease liabilities - non-current	—	112,064
Total liabilities	8,020,041	2,860,497
Commitments and contingencies (Note 8)
Stockholders' equity:
Preferred stock, $0.001 par value; 10,000,000 shares authorized; no shares issued or outstanding	—	—
Common stock—$0.001 par value; 200,000,000 shares authorized; 91,879,177 and 89,704,194 issued and outstanding at December 31, 2025 and December 31, 2024, respectively	91,879	89,704
Additional paid-in capital	191,285,157	189,956,252
Accumulated deficit	(130,903,309)	(94,779,694)
Total stockholders' equity	60,473,727	95,266,262
Total liabilities and stockholders' equity	$68,493,768	$98,126,759

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.